ClinVar Miner

Submissions for variant NM_153704.6(TMEM67):c.1319G>A (p.Arg440Gln) (rs386834182)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000430117 SCV000521233 likely pathogenic not provided 2016-09-02 criteria provided, single submitter clinical testing The R440Q variant in the TMEM67 gene has been reported previously in multiple individuals with Joubert syndrome and related disorders in the homozygous state, as well as in the heterozygous state in the presence of a second TMEM67 variant (Consugar et al., 2007; Khaddour et al., 2007; Brancati et al., 2009; Tallila et al., 2009; Iannicelli et al., 2010; Westerfield et al., 2015; Watson et al., 2016). Additionally, functional and expression studies in mouse models indicate that the R440Q variant impacts the function of the protein (Abdelhamed et al., 2015). The R440Q variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R440Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. The R440Q variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.
Baylor Genetics RCV000050177 SCV000807624 uncertain significance Meckel syndrome, type 3 2017-09-01 criteria provided, single submitter clinical testing This variant has been previously reported as disease-causing and was found once in our laboratory in trans with another variant (C78Y) in a fetus with features of Meckel-Gruber syndrome. A second affected fetus from this family was also compound heterozygous for these variants. Heterozygotes are expected to be asymptomatic carriers.
Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) RCV000050177 SCV000082587 probable-pathogenic Meckel syndrome, type 3 no assertion criteria provided not provided Converted during submission to Likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.